Time to endovascular reperfusion and degree of disability in acute stroke

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

(2015) Jeffrey L. Saver et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

(2015) Mayank Goyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection

(2015) Bruce C.V. Campbell et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

(2015) Olvert A. Berkhemer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

(2014) Pooja Khatri et al.   LANCET NEUROLOGY

Optimal Workflow and Process-Based Performance Measures for Endovascular Therapy in Acute Ischemic Stroke

(2014) Bijoy K. Menon et al.   STROKE

“Picture to Puncture”

(2013) Chung-Huan J. Sun et al.   CIRCULATION

Impact of Onset-to-Reperfusion Time on Stroke Mortality

(2013) Mikael Mazighi et al.   CIRCULATION

Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke

(2013) Jeffrey L. Saver et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prospective, Multicenter, Single-Arm Study of Mechanical Thrombectomy Using Solitaire Flow Restoration in Acute Ischemic Stroke

(2013) Vitor M. Pereira et al.   STROKE

Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes

(2012) Rishi Gupta et al.   Journal of NeuroInterventional Surgery

Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial

(2012) Jeffrey L Saver et al.   LANCET

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial

(2012) Raul G Nogueira et al.   LANCET

A Simple, Assumption-Free, and Clinically Interpretable Approach for Analysis of Modified Rankin Outcomes

(2012) George Howard et al.   STROKE

Statistical Analysis of the Primary Outcome in Acute Stroke Trials

(2012) Philip M.W. Bath et al.   STROKE

Optimal End Points for Acute Stroke Therapy Trials

(2011) Jeffrey L. Saver   STROKE

Effect of Time to Reperfusion on Clinical Outcome of Anterior Circulation Strokes Treated With Thrombectomy

(2011) Raul G. Nogueira et al.   STROKE

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Good clinical outcome after ischemic stroke with successful revascularization is time-dependent

(2009) P. Khatri et al.   NEUROLOGY

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window

(2009) Jeffrey L. Saver et al.   STROKE

Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale

(2009) Maarten G. Lansberg et al.   STROKE

A Brief Prehospital Stroke Severity Scale Identifies Ischemic Stroke Patients Harboring Persisting Large Arterial Occlusions

(2008) Bijen Nazliel et al.   STROKE